Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.331 $0.440 Thursday, 9th May 2024 GLMD stock ended at $0.415. This is 6.71% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 13.51% from a day low at $0.370 to a day high of $0.420.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
Oct 20, 2016 $3.90 $4.09 $3.55 $3.91 96 600
Oct 19, 2016 $4.18 $4.19 $3.95 $4.00 48 700
Oct 18, 2016 $3.84 $4.19 $3.84 $4.11 71 800
Oct 17, 2016 $3.85 $3.99 $3.62 $3.85 29 500
Oct 14, 2016 $3.81 $3.96 $3.61 $3.93 100 000
Oct 13, 2016 $4.02 $4.21 $3.66 $3.84 125 700
Oct 12, 2016 $4.20 $4.36 $3.95 $3.96 72 400
Oct 11, 2016 $4.33 $4.51 $4.17 $4.18 31 700
Oct 10, 2016 $4.30 $4.49 $4.16 $4.40 55 100
Oct 07, 2016 $4.56 $4.61 $4.30 $4.30 27 100
Oct 06, 2016 $4.66 $4.73 $4.37 $4.37 31 300
Oct 05, 2016 $4.53 $4.74 $4.35 $4.62 69 100
Oct 04, 2016 $4.54 $4.74 $4.46 $4.51 19 800
Oct 03, 2016 $4.37 $4.71 $4.35 $4.56 70 800
Sep 30, 2016 $4.57 $4.57 $4.35 $4.44 51 800
Sep 29, 2016 $4.83 $4.83 $4.36 $4.60 197 100
Sep 28, 2016 $5.15 $5.29 $4.88 $4.91 186 100
Sep 27, 2016 $5.36 $5.36 $5.05 $5.20 104 700
Sep 26, 2016 $5.29 $5.40 $5.05 $5.30 251 800
Sep 23, 2016 $5.77 $5.77 $5.15 $5.22 736 200
Sep 22, 2016 $4.86 $5.59 $4.75 $5.50 1 443 800
Sep 21, 2016 $4.62 $4.75 $4.22 $4.64 500 300
Sep 20, 2016 $4.75 $5.39 $4.44 $4.61 862 700
Sep 19, 2016 $3.65 $3.68 $3.65 $3.67 2 500
Sep 16, 2016 $3.65 $3.75 $3.61 $3.68 4 900
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT